Epidemiology & Prevention of cardiovascular diseases

2,267 views 24 slides Mar 29, 2020
Slide 1
Slide 1 of 24
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24

About This Presentation

Cardiovascular Diseases, Epidemiology, Prevention


Slide Content

Epidemiology of Cardiovascular
Diseases
Dr. Athar Khan
Department of CommunityMedicine
Liaquat College of Medicine & Dentistry
Karachi
[email protected]

Learning Objectives
▪DiscussEpidemiology of Cardiovascular Diseases
▪Listthe Risk Factors of Cardiovascular Diseases
▪IdentifyNew Emerging Cardiovascular Risk Factors
▪Listthe preventive factors of Cardiovascular Diseases
3/29/2020 DR ATHAR KHAN -LCMD 2

Cardiovascular Diseases
▪“Cardiovascular diseases (CVD) is a class of diseases
that involve the Heartor Blood Vessels”.
▪WHO
3/29/2020 DR ATHAR KHAN -LCMD 3

Cardiovascular Diseases
▪CardiovascularDiseases
IncludeTheFollowing:
▪CoronaryHeartDisease
▪CerebrovascularDisease
▪Peripheral Arterial
Disease
▪RheumaticHeartDisease
▪CongenitalHeartDisease
▪DeepVeinThrombosis
▪PulmonaryEmbolism
▪Cardiovascular Diseases Include The Following:
3/29/2020 DR ATHAR KHAN -LCMD 4

Cardiovascular Diseases
▪Heart Attacks and Strokes are
usually Acute Events and are
mainly caused by a Blockage.
▪The cause of Heart Attacks
and Strokes are usually the
presence of a combination of
risk factors such as:
▪Tobacco use
▪Unhealthy Diet
▪Obesity
▪Physical Inactivity
▪Harmful use of Alcohol
▪Hypertension
▪Diabetes
▪Hyperlipidemia.
3/29/2020 DR ATHAR KHAN -LCMD 5

Epidemiology of Cardiovascular Diseases
3/29/2020 DR ATHAR KHAN -LCMD 6

Over 80% of all premature NCD deaths
3/29/2020 DR ATHAR KHAN -LCMD 7

3/29/2020 DR ATHAR KHAN -LCMD 8

3/29/2020 DR ATHAR KHAN -LCMD 9

Risk Factors of Cardiovascular Diseases
3/29/2020 DR ATHAR KHAN -LCMD 10

Risk Factors of Cardiovascular Diseases
Modifiable:
❑Raised Systolic BloodPressure
❑Raised Diastolic BloodPressure
❑Smoking
❑Raised LDLCholesterol
❑Reduced HDLCholesterol
❑Left Ventricular Hypertrophy
❑Hyperglycemia
3/29/2020 DR ATHAR KHAN -LCMD 11

Risk Factors of Cardiovascular Diseases
Modifiable Behavioural
Risk Factors
❑Physical inactivity
❑Unhealthy diet
❑Tobacco use
❑Harmful use of alcohol
Modifiable Metabolic Risk
Factors
❑Raised blood pressure
❑Overweight/obesity
❑Hperglycemia(high blood
glucose levels) and
❑Hyperlipidemia (high
levels of fat in the blood)
3/29/2020 DR ATHAR KHAN -LCMD 12

Risk Factors of Cardiovascular Diseases
Non-Modifiable:
❑Age
❑Gender
❑FamilyHistory
❑Previous CardiovascularEvents
❑Previous Cerebro-VascularEvents
3/29/2020 DR ATHAR KHAN -LCMD 13

New Emerging Cardiovascular Risk Factors
Thecommonemergingcardiovascularriskfactors
included:
▪Coronaryarterycalciumscore
▪Lipoprotein(a)
▪Homocysteine
▪C-reactiveprotein
▪Fibrinogen
▪Plasminogenactivatorinhibitor1
3/29/2020 DR ATHAR KHAN -LCMD 14

3/29/2020 DR ATHAR KHAN -LCMD 15

Preventive factors of Cardiovascular Diseases
PRIMARYPREVENTION:
▪HealthEducation
▪HealthyDietPattern
▪PhysicalActivity
▪SmokingCessation
▪ReducetheintakeoffoodsthatareHighinFat,
SugarandSalt
▪AbstinencefromAlcohol
3/29/2020 DR ATHAR KHAN -LCMD 16

3/29/2020 DR ATHAR KHAN -LCMD 17

Preventive factors of Cardiovascular Diseases
SECONDARY PREVENTION:
▪TreatmentwiththefollowingMedicationsare
necessary:
▪Aspirin
▪Beta-Blockers
▪Angiotensin-ConvertingEnzymeInhibitors
▪Statins
ThebenefitsoftheseInterventionsarelargelyeffectivewhenused
togetherwithSmokingCessationandhaveleadtoPreventionof75%of
Recurrentvascularevents.
3/29/2020 DR ATHAR KHAN -LCMD 18

Preventive factors of Cardiovascular Diseases
SECONDARY PREVENTION:
▪Angioplasty
▪CoronaryArteryBypassGraft(CABG)
ThebenefitsoftheseInterventionsarelargelyeffectivewhenused
togetherwithSmokingCessationandhaveleadtoPreventionof75%of
Recurrentvascularevents.
3/29/2020 DR ATHAR KHAN -LCMD 19

3/29/2020 DR ATHAR KHAN -LCMD 20

Framingham Heart Study
TheFraminghamHeartStudyisa
Long- Term, ongoing
CardiovascularCohortStudyon
residentsofthetownofFramingham,
Massachusetts.
Thestudybeganin1948with5,209
AdultSubjectsfromFramingham,
andisnowonitsThirdGeneration
ofparticipants.
3/29/2020 DR ATHAR KHAN -LCMD 21

3/29/2020 DR ATHAR KHAN -LCMD 22

❑Life CourseApproach
❑Empowerment of People andCommunities
❑Evidence basedStrategies
❑Universal HealthCoverage
❑Management of conflicts ofinterest
❑Human RightsApproach
❑National and InternationalCooperation
❑MultisectoralActions
Global NCD Action Plan 2013-2020
3/29/2020 DR ATHAR KHAN -LCMD 23
Tags